Atom | Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Funding Amounts: Application budgets are not limited but must reflect actual project needs; project period up to 3 years.

Summary: Supports discovery research for developing and screening small molecules as chemical probes or therapeutic leads targeting cancer biology and immunomodulation.

Key Information: Clinical trials are not allowed; applications may focus on assay development, primary screening, or hit validation stages.

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing